Search
State of Possible: Strand Therapeutics' Co-Founder & CEO Jake Becraft talks mRNA and getting into the clinic with the company's first program
He describes the intratumoral IL-12 program that is in the clinic today, and the preclinical progress Strand is making on its other...
2 days ago
The next generation of mRNA beyond vaccines with Strand Therapeutics
Jake Becraft describes emerging new techniques in using mRNA and gives BiotechTV a tour of Strand’s Fenway HQ to show us the R&D process.
Sep 5, 2023
.png){kind=logo}
